节点文献

依那普利叶酸片固定复方与依那普利和叶酸自由联合在H型高血压人群中降低同型半胱氨酸的疗效比较

Efficacy of fixed vs.free combination of enalapril-folic acid tablet in controlling elevated plasma homocysteine in patients with H-type hypertension

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 孙宁玲秦献辉李建平关德明葛均波胡健王燕妮张馥敏唐海沁傅佳霍勇

【Author】 SUN Ning-ling1,QIN Xian-hui2,LI Jian-ping3,GUAN De-ming4,GE Jun-bo5,HU Jian6,WANG Yan-ni7,ZHANG Fu-min8,TANG Hai-qin9,FU Jia10,HUO Yong3 (1Department of Cardiology,People’s Hospital of Peking University,Beijing 100044,China;2 Institute for Biomedicine,Anhui Medical University,Hefei 230032,China;3 Department of Cardiology,First Hospital of Peking University,Beijing 100034,China;4 First Clinical Medical College of Harbin Medical University,Harbin 150001,China;5 Zhongshan Hospital Fudan University,Shanghai 200032,China;6 First Affiliated Hospital of China Medical University,Shenyang 110001,China;7 First Affiliated Hospital of the School of Medicine,Xi’an Jiaotong University,Xi’an 710061,China;8 First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China;9 Department of Geriatric Cardiology,First Affiliated Hospital of Anhui Medical University,Hefei 230022,China;10 Department of Neurology,First Affiliated Hospital of Anhui Medical University,Hefei 230022,China)

【机构】 北京大学人民医院心内科安徽医科大学安徽省生物医学研究所北京大学第一医院心内科哈尔滨医科大学第一临床医院复旦大学附属中山医院中国医科大学附属第一医院西安交通大学第一医院南京医科大学第一附属医院安徽医科大学第一附属医院老年心血管内科安徽医科大学第一附属医院神经内科

【摘要】 目的:比较依那普利加叶酸(自由联合)与依那普利叶酸片(固定复方)降低同型半胱氨酸(Hcy)疗效的差异,为中国H型高血压人群高Hcy的控制提供可选用的更有效的治疗方案。方法:对原发性高血压患者采用依那普利和叶酸联合方式治疗8周,根据联合方式的不同分为自由联合和固定复方的2种方案。自由联合方案中共入选241例原发性高血压患者,其中79例进入依那普利10 mg加叶酸0.4 mg组(叶酸低剂量组),82例进入依那普利10 mg加叶酸0.8 mg组(叶酸高剂量组),80例进入依那普利10 mg单药组。固定复方联合方案中,共入选了456例原发性高血压患者,其中151例进入依那普利10 mg叶/酸0.4mg组(叶酸低剂量),152例进入依那普利10 mg叶/酸0.8 mg(叶酸高剂量),153例进入依那普利10 mg单药组。所有患者治疗前、后均采用高效液相色谱法测定Hcy。结果:自由联合用药方案中,叶酸高剂量组在降低Hcy、降压或降Hcy方面疗效均低于叶酸低剂量组,未体现出合理的量效关系,提示患者服用多片叶酸的治疗依从性较差;在固定复方用药方案中,叶酸高剂量组降低Hcy、降压或降Hcy方面疗效均高于于叶酸低剂量组,呈现明显的剂量反应关系。固定复方方案中叶酸高剂量组较自由联合方案中叶酸高剂量组降低Hcy相对有效率提高10%,降压或降Hcy相对有效率提高22%。结论:固定复方制剂依那普利叶酸片具有更好的控制H型高血压患者Hcy的疗效。

【Abstract】 Objective:H-type hypertension,defined as having both elevated plasma homocysteine level and hypertension,constitutes about 70% of the Chinese hypertensive patients.This study was to compare therapeutic efficacy of lowering plasma total homocystein(tHcy) using a fixed combination vs.a free combination of enalapril and folic acid tablets in hypertensive patients.Methods:This report included two trials in China.The first had a total of 241 hypertensive patients,randomly assigned to ① Enalapril(10mg,control);② Enalapril(10mg) pill and folic acid 0.4mg pill(low FA);and ③ Enalapril(10mg) pill and folic acid 0.8mg pill(high FA),once daily for 8 weeks.The second had a total of 456 hypertensive patients,randomly assigned to ① Enalapril(10mg,control);② a single pill containing Enalapril(10mg) + folic acid 0.4mg;and ③ a single pill containing Enalapril(10mg) + folic acid 0.8mg,once daily for 8 weeks.Plasma homocysteine(Hcy) levels were measured for each patient at baseline,4th and 8th week of the trial.Results:Dose-response effect was only observed in fixed combination regime of enalapril and folic acid,that means the low compliance in free combination regime.Comparing with the enalapril/low-dose folic acid group,the enalapril/high-dose folic acid group in the fixed combination regime had a moderately higher hcy lowering rate and hcy or hypertension lowering rate,by 10% and 22% respectively than in the free combination regime with the enalapril/high-dose-folic acid.Conclusion:The fixed combination regime with the enalapril/high-dose folic acid appeared to have a better efficacy in controlling H-type hypertension than the the free combination regime.

  • 【文献出处】 中国新药杂志 ,Chinese Journal of New Drugs , 编辑部邮箱 ,2009年17期
  • 【分类号】R544.1
  • 【被引频次】137
  • 【下载频次】1862
节点文献中: 

本文链接的文献网络图示:

本文的引文网络